The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Agarwal Shefali since 2019.
This trader's CIK number is 1746830.
At the time of last reporting, Agarwal Shefali was the Other of Epizyme, Inc.. (stock ticker symbol EPZM).
Also see all insider trading activities at Epizyme, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2022 | FATE | 0 | $0 | 1,648 | $36,808 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2022 | EPZM | 0 | $0 | 6,619 | $11,104 | 500,000 | $695,000 |
2021 | EPZM | 0 | $0 | 5,621 | $48,846 | 0 | $0 |
2020 | EPZM | 0 | $0 | 10,043 | $181,458 | 0 | $0 |
2019 | EPZM | 0 | $0 | 1,195 | $14,304 | 0 | $0 |
1. Fate Therapeutics Inc (FATE)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2022-06-07 | FATE | Sale | 841 | 21.89 | 18,409 |
2022-06-03 | FATE | Sale | 807 | 22.80 | 18,399 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2022-08-09 | EPZM | Option Ex | 500,000 | 1.39 | 695,000 |
2022-02-07 | EPZM | Sale | 1,058 | 1.50 | 1,587 |
2022-02-02 | EPZM | Sale | 2,639 | 1.37 | 3,615 |
2022-01-26 | EPZM | Sale | 2,922 | 2.02 | 5,902 |
2021-12-06 | EPZM | Sale | 1,780 | 2.93 | 5,215 |
2021-02-04 | EPZM | Sale | 969 | 11.21 | 10,862 |
2021-01-25 | EPZM | Sale | 2,872 | 11.41 | 32,769 |
2020-12-03 | EPZM | Sale | 2,522 | 13.54 | 34,147 |
2020-06-26 | EPZM | Sale | 1,805 | 16.15 | 29,150 |
2020-03-25 | EPZM | Sale | 1,243 | 15.28 | 18,993 |
2020-01-27 | EPZM | Sale | 2,630 | 20.44 | 53,757 |
2020-01-24 | EPZM | Sale | 1,843 | 24.64 | 45,411 |
2019-06-14 | EPZM | Sale | 1,195 | 11.97 | 14,304 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Agarwal Shefali (Other of Epizyme, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.